Brief Reports Open Access
Copyright ©The Author(s) 2001. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 15, 2001; 7(3): 419-421
Published online Jun 15, 2001. doi: 10.3748/wjg.v7.i3.419
Influence of IFNα-2b and BCG on the release of TNF and IL-1 by Kupffer cells in rats with hepatoma
Xian-Yong Bai, Department of Histology and Embryology, Binzhou Medical College, Binzhou 256603, Shandong Province, China
Xiu-Hong Jia, Department of Pediatrics, Binzhou Medical College, Binzhou 256603, Shandong Province, China
Ling-Zhong Cheng, Yun-Di Gu, Department of Histology and Embryology, Shanghai Medical University, Shanghai 200032, China
Author contributions: All authors contributed equally to the work.
Supported by the National Natural Science Foundation of China, No. 39270379
Correspondence to: Dr. Xian-Yong Bai, Department of Histology and Embryology, Binzhou Medical College, Binzhou 256603, Shandong Province, China. bzbaixy@sina.com
Telephone: +86-543-3323516 Fax: +86-543-3322752
Received: November 13, 2000
Revised: November 23, 2000
Accepted: November 30, 2000
Published online: June 15, 2001

Abstract
Key Words: gastrointestinal diseases/metabolism, gastrins/analysis, somatostatin/analysis, G cells/secretion, D cells/secretion



INTRODUCTION

Kupffer cells are residential macrophages in the liver, which play a critical role in the maintenance of normal liver function and in immunal surveilance of hepatocellular carcinoma (HCC) and other cancers[1]. The biological immune modulants have been used for treating patients with HCC and other cancers[2]. In our previous studies, the combined use of biological immune modulants showed better effects. The normal rats and hepatoma rats induced by DEN (Diethylnitrosamine) were treated by either IFNα-2b or BCG or both, the number of KCs and the amount of H2O2 released increased obviously, while the combined use of IFNα-2b and BCG showed the best results[3,4]. This study was focused on the influence of biological immune modulants on the release of TNF and IL-1 by KCs in rats with hepatoma.

MATERIALS AND METHODS
Animals

Male Wistar rats weighing 150-200 g, were provided by the Experimental Animal Center of the Chinese Academy of Medical Sciences. The rats were given drinking water containing 0.008% DEN for 12 weeks, then randomly divided into four groups, they were given IFNα-2b (Schering-Plough Co. USA) at a dose of 16 U/kg, BCG (Biological Product's Research Institute, Shanghai) at a dose of 0.1 mg/kg, and combination of the two intraperitoneally, the controls were given the same volume of normal saline at various survival periods (12th week, 16th week).

Isolation of KCs

Under anesthesia, the rats were exsanguinated and the livers were perfused in situ via the portal vein with Hank's balanced salt solution (HBSS). The livers were dissected free and passed through 60 μm brass screens into HBSS. Following centrifugation at 500 × g for 10 min (4 °C), the pellet was resuspended in 30 mL HBSS containing 0.05% collagenase (TYPE I, Sigma) and 0.1% pronase (TYPE E, Sigma), and incubated for 30 min in a 37 °C agitating water bath, following centrifugation at 500 × g for 2 min to sediment the hepatocytes, an enriched nonparenchymal cell pellet was obtained by centrifugation of the supernatant at 500 × g for 35 min. Erythrocytes were lysed by incubation for 3-5 min with ammonium chloride (0.83%). The cells were washed twice with HBSS and resuspended in standard RPMI-1640. After 4 h incubation at 37 °C in 100 mm plastic petridishes, the nonadherent cells were removed by three successive wash with warm HBSS. The adherent cells, phagocytosing latex beads (Sigma) were designated as Kupffer cells. After 10 min incubation at 37 °C in Trypsin-EDTA (0.05%/0.02%), KCs were liberated from the plastic dishes by vigorous pipetting, washing, and counted. The purity of KC was > 95% by latex bead ingestion and viability was > 90% as indicated by trypan blue exclusion (0.4% trypan blue stain in 0.85% salin). The KCs of control hepatoma rats (at the 18th week) were isolated and treated with IFNα-2b (2500 U/mL), BCG(2 mg/L) or both respectively. The human hepatoma cell line SMMC-7721 cells and KCs were cocultured in the RPMI-1640 medium supplemented with 10% fetal bovine serum at 37 °C in a humidified atmosphere containing 5% CO2 for 4 h. Supernatants were collected, and stored at -20 °C until use.

IL-1 activity assay

IL-1 activity in the culture supernatants was assayed by the enhancement of thymocyte proliferation to concanavalin A (ConA). Briefly, thymocytes were obtained from female C57BL/6N mice at 5-7 weeks of age, cell suspensions of thymocytes were prepared by pressing the thymus tissue through a 50 μm wire mesh, then filtering the tissue fragments through a 30 μm nylon mesh into RPMI-1640 medium supplemented with 2.4 g/L ConA. The cells were resuspended to 1.5 × 106 cells/mL, and 100 μL of cell suspensions were placed in each well of 96-well microtiter plates, 100 μL of supernatants were added to each well and the plates were incubated for 72 h. Each cell culture well was plused 3.7 × 1010μBq3H-thymidine during the final 8 h of incubation and harvested onto glass fibers, using an automatic cell harvester, 3H-thymidine incorporation was determined by a liquid scintillation spectrometer, the enhancement of thymocyte proliferation of the unknown supernatant IL-1 levels was determined by the ratio of radioactivity incorporated in the experimental and control groups (SI).

TNF assay

The levels of TNF in culture supernatants were determined by a TNF specific ELISA obtained from Institute of Military Medical Sciences. The kit was composed of 96 determinations and the assays were performed exactly as recommended by the manufacturer. All samples were assayed in triplicate.

Statistical analysis

The results were presented as the mean of triplicates ± SEM, and statistical significance was assessed by Student's t test.

RESULTS

The influence of biological immune modulants on the release of TNF by KCs of normal rats in vivo (Table 1). The KCs of normal rats could release a little TNF and IL-1 when cocultured with human SMMC-7721 hepatoma cells, the TNF and IL-1 released by KCs of normal rats treated with biological immune modulants in vivo increased obviously. The effect of combined use of IFNα-2b and BCG exhibited the best effects, the combination of IFNα-2b and BCG increased the production of TNF by 3.5 times and the activity of IL-1 by 80%. BCG was better than IFNα-2b in increasing the release of IL-1, and IFNα-2b was better in increasing the production of TNF.

Table 1 The influence of biological immunal modulants on the release of TNF and IL-1 by KCs of normal rat in vivo.
GroupsTNF (ng/L)IL-1 (SI)
Control56.2 ± 10.51.40
BCG79.4 ± 17.6a2.27b
IFNα-2b134.9 ± 51.4b1.84a
IFNα-2b + BCG199.5 ± 71.5b2.54b

The influence of biological immune modulants on the release of TNF and IL-1 by KCs of rat with hepatoma in vivo is shown in Table 2. The influence of biological stimulants on the release of TNF and IL-1 by KCs of rats with hepatoma in vivo was similar to those of normal rats. The combined use of IFNα-2b and BCG exhibited the best effect, the amount of TNF released by KCs treated with IFNα-2b and BCG increased by 5.6 times (12th week) and by 4.5 times (16th week), the activity of IL-1 increased by KCs treated with IFNα-2b and BCG increased by 48% (12th week) and 78% (16th week).

Table 2 The influence of biological immunal modulants on the release of TNF and IL-1 by KCs of rats with hepatoma in vivo.
Groups2nd week
16th week
TNF (ng/L)IL-1 (SI)TNF (ng/L)IL-1 (SI)
Control50.1 ± 9.41.5779.4 ± 10.61.58
BCG234.4 ± 63.1b2.58b148.5 ± 47.2a2.74b
IFNα-2b251.2 ± 82.1b2.33b166.0 ± 30.5a2.42b
IFN-2b + BCG281.8 ± 63.3b2.80b354.8 ± 96.4b4.08b

The influence of biological immune modulants on the release of TNF and IL-1 by KCs of rat with hepatoma in vitro is shown in Table 3. The influence of biological stimulants on the release of TNF and IL-1 by KCs of rats with hepatoma in vitro was similar to the result in vivo. IFNα-2b was better than BCG in increase of release of TNF by KCs, BCG gave better results than IFNα-2b in increasing the activity of IL-1 released by KCs. The combined IFNα-2b and BCG exhibited the best effects, the amount of TNF released by KCs treated with IFNα-2b and BCG increased by 123.8%, the activity of IL-1 released by KCs treated with IFNα-2b and BCG increased by 58%.

Table 3 The influence of biological immune modulants on the release of TNF and IL-1 by KCs of rats with hepatoma in vitro.
GroupsTNF (ng/L)IL-1 (SI)
Control100.0 ± 20.61.42
BCG141.3 ± 31.7b1.80a
IFNα-2b199.5 ± 61.2b1.64a
IFNα-2b + BCG223.8 ± 42.4b2.24b
DISCUSSION

TNF and IL-1 are macrophage-derived cytokines, TNF is known to have cytotoxic and cytostatic effects on certain tumor cells, and with a pivotal role in inflammatory reactions and regulation of immunological response[5,6]. The actions of IL-1 have been elucidated in recent years, it is directly cytotoxic for some human tumor cells, and stimulates T cell proliferation by inducing production of interleukin 2 (IL-2) as well as increasing the number of IL-2 receptors on the T cell, and directly stimulate NK cell activity[7]. Kupffer cells are residential macrophages in the liver, and play an important role as scavenger cells in nonspecific elimination of gut endotoxins, immune complexes and viruses[8], especially the important role in immunal surveillance on HCC[9,10]. Kupffer cells have also been reported to release some cytokines when activated by biologically reactive substances, several reports have suggested that IFN-γ regulates monocytic function, especially in the production of TNF and IL-1. Kawada had shown that IFN-γ enhanced TNF production in the presence or absence of lipopolysaccharide (LPS), but suppressed IL-1 production by KCs[11]. Brandwein showed that IFN-γ markedly inhibits LPS-stimulated IL-1 production by mouse peritoneal macrophages[12], but differed from the observations of Boraschi and Hart[13,14]. Amento et al[15] have also observed that IFN-γ did not stimulate IL-1 production by macrophages from the human monocyte cell line U937, and many reports had suggested that IFN-γ augments both TNF and IL-1 production by macrophages only in the presence of LPS[12], this variable responses are undoubtedly related to the difference in both the interferon preparations and the responder cell types. Our study showed that IFNα-2b stimulated and enhanced TNF and IL-1 production by KCs in the absence of LPS, the difference may have resulted from the cell types and condition of macrophages, since KCs may always be exposed to endotoxins and activated to some degree[16]. In our previous studies, anti-tumor effects of KCs activated by various biological immunal modulants were different, but the combined use of various biological immunal stimulants showed the best effect[2]. Our previous studies of the mechanism of KCs function also showed that the combination of IFNα-2b and BCG exhibited the best results, the increase of the number and volume of KCs, the increase of the amount of H2O2 released by KCs[3,4]. The systematic study mentioned above, regardless of normal or hepatoma rats and both in vivo and vitro consistently confirmed the combined use of IFNα-2b and BCG was better than either one used alone in enhancing the activity of immune cells. These results suggested that the combined use of IFNα-2b and BCG to HCC patients should be advocated.

Footnotes

Dr. Xian-Yong Bai, graduated from the Shanghai Medical University as a postgraduate in 1995, Professor of Histology and Embryology, specialized in hepatic tumor immunology, having 36 papers published.

Edited by Wu XN and Ma JY

References
1.  Nolan JP. Endotoxin, reticuloendothelial function, and liver injury. Hepatology. 1981;1:458-465.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 275]  [Cited by in F6Publishing: 265]  [Article Influence: 6.2]  [Reference Citation Analysis (0)]
2.  Han W, Cheng LZ, Gu YD, Zhu JH, Lin ZY, Tang ZY. In vitro cytostatic of human kupffer cells and monocytes activated by immune stimulants on human hepatoma. Shanghai Yike Daxue Xuebao. 1989;16:161-165.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Bai XY, Gu YD, Zhu JH, Zhong CP, Cheng LZ. Influence of immune stimulants on the number and area of kupffer cells in rat liver. Shanghai Yike Daxue Xuebao. 1994;21:277-280.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Bai XY, Gu YD, Zhu JH, Zhong CP, Cheng LZ. Effects of immune stimulants on H2O2 release of rat Kupffer cells in vitro. Jiepouxue Zazhi. 1994;17:331-334.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Semenzato G. Tumour necrosis factor: a cytokine with multiple biological activities. Br J Cancer. 1990;61:354-361.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 69]  [Cited by in F6Publishing: 80]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
6.  Zhou LS, Shi JS, Wang ZR, Wang L. Tumor necrosis factor-α in gallbladder and gallstone. Shijie Huaren Xiaohua Zazhi. 2000;8:426-428.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Hill AD, Redmond HP, Croke DT, Grace PA, Bouchier-Hayes D. Cytokines in tumour therapy. Br J Surg. 1992;79:990-997.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 25]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
8.  Zhao LF, Li H, Han DW. Intestinal endotoxemia and liver diseases. Shijie Huaren Xiaohua Zazhi. 2000;8:1145-1149.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Jones EA, Summerfield JA. Kupffer cells. The liver: biology and pathobiology. New York: Raven Press 1982; 507-523.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Zhu HZ, Ruan YB, Wu ZB, Zhang CM. Kupffer cell and apoptosis in experimental HCC. World J Gastroenterol. 2000;6:405-407.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Kawada N, Mizoguchi Y, Kobayashi K, Morisawa S, Monna T, Yamamoto S. Interferon gamma modulates production of interleukin 1 and tumor necrosis factor by murine Kupffer cells. Liver. 1991;11:42-47.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 17]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
12.  Brandwein SR. Regulation of interleukin 1 production by mouse peritoneal macrophages. Effects of arachidonic acid metabolites, cyclic nucleotides, and interferons. J Biol Chem. 1986;261:8624-8632.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Boraschi D, Censini S, Tagliabue A. Interferon-gamma reduces macrophage-suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 production. J Immunol. 1984;133:764-768.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Hart PH, Whitty GA, Piccoli DS, Hamilton JA. Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-gamma. Increased TNF-alpha but not IL-1 activity. J Immunol. 1988;141:1516-1521.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Amento EP, Kurnick JT, Krane SM. Interleukin 1 production by the human monocyte cell line U937 requires a lymphokine induction signal distinct from interleukin 2 or interferons. J Immunol. 1985;134:350-357.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Zhao LF, Han DW. Clinical significance of endotoxemia in liver diseases. Shijie Huaren Xiaohua Zazhi. 1999;7:391-393.  [PubMed]  [DOI]  [Cited in This Article: ]